Metaclipse Therapeutics is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with immune-stimulatory molecules.
Company (Alive / Active)
3175 Presidential Drive
Georgia, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Methods of treating with tumor membrane vesicle-based immunotherapy and predicting therapeutic response thereto||Nov 08, 2017||Application|